Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREGCindy Franklin, Selma Ugurel, Carsten Weishaupt et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 19
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREGMaximilian Haist, Carmen Loquai, Henner Stege et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 18
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, N. Devereux, Tim Zell et al.|European Journal of Cancer|2024Cited by 16
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREGCindy Franklin, Selma Ugurel, Peter Mohr et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 14
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREGAnne Zaremba, Lisa Zimmer, Peter Mohr et al.|European Journal of Cancer|2023Cited by 13